These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36124494)

  • 1. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
    Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
    Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
    Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
    BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
    N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
    Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
    Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG vaccination strategies against tuberculosis: updates and perspectives.
    Qu M; Zhou X; Li H
    Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?
    Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T
    Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
    Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
    Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the BCG vaccine and its future scope.
    Khandelia P; Yadav S; Singh P
    Indian J Tuberc; 2023; 70 Suppl 1():S14-S23. PubMed ID: 38110255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
    Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
    Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
    Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India.
    Narayanan PR
    Indian J Med Res; 2006 Feb; 123(2):119-24. PubMed ID: 16575109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
    Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
    BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.
    Hatherill M; Geldenhuys H; Pienaar B; Suliman S; Chheng P; Debanne SM; Hoft DF; Boom WH; Hanekom WA; Johnson JL
    Vaccine; 2014 Jun; 32(31):3982-8. PubMed ID: 24814553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
    Glynn JR; Dube A; Fielding K; Crampin AC; ; Kanjala C; Fine PEM
    Lancet Infect Dis; 2021 Nov; 21(11):1590-1597. PubMed ID: 34237262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
    Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.
    Tala-Heikkilä MM; Tuominen JE; Tala EO
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1324-7. PubMed ID: 9563757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.